Literature DB >> 24497632

Unique functional properties of conserved arginine residues in the lentivirus lytic peptide domains of the C-terminal tail of HIV-1 gp41.

Anne-Sophie Kuhlmann1, Jonathan D Steckbeck, Timothy J Sturgeon, Jodi K Craigo, Ronald C Montelaro.   

Abstract

A previous study from our laboratory reported a preferential conservation of arginine relative to lysine in the C-terminal tail (CTT) of HIV-1 envelope (Env). Despite substantial overall sequence variation in the CTT, specific arginines are highly conserved in the lentivirus lytic peptide (LLP) motifs and are scarcely substituted by lysines, in contrast to gp120 and the ectodomain of gp41. However, to date, no explanation has been provided to explain the selective incorporation and conservation of arginines over lysines in these motifs. Herein, we address the functions in virus replication of the most conserved arginines by performing conservative mutations of arginine to lysine in the LLP1 and LLP2 motifs. The presence of lysine in place of arginine in the LLP1 motif resulted in significant impairment of Env expression and consequently virus replication kinetics, Env fusogenicity, and incorporation. By contrast, lysine exchanges in LLP2 only affected the level of Env incorporation and fusogenicity. Our findings demonstrate that the conservative lysine substitutions significantly affect Env functional properties indicating a unique functional role for the highly conserved arginines in the LLP motifs. These results provide for the first time a functional explanation to the preferred incorporation of arginine, relative to lysine, in the CTT of HIV-1 Env. We propose that these arginines may provide unique functions for Env interaction with viral or cellular cofactors that then influence overall Env functional properties.

Entities:  

Keywords:  Arginines; C-terminal Tail; Envelope; HIV-1; Lentivirus; Membrane Proteins; Site-directed Mutagenesis; Viral Replication

Mesh:

Substances:

Year:  2014        PMID: 24497632      PMCID: PMC3953275          DOI: 10.1074/jbc.M113.529339

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  A structural correlation between lentivirus transmembrane proteins and natural cytolytic peptides.

Authors:  M A Miller; R F Garry; J M Jaynes; R C Montelaro
Journal:  AIDS Res Hum Retroviruses       Date:  1991-06       Impact factor: 2.205

Review 2.  The role of antibodies in HIV vaccines.

Authors:  John R Mascola; David C Montefiori
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

3.  Highly conserved structural properties of the C-terminal tail of HIV-1 gp41 protein despite substantial sequence variation among diverse clades: implications for functions in viral replication.

Authors:  Jonathan D Steckbeck; Jodi K Craigo; Christopher O Barnes; Ronald C Montelaro
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

4.  Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein.

Authors:  M A Miller; M W Cloyd; J Liebmann; C R Rinaldo; K R Islam; S Z Wang; T A Mietzner; R C Montelaro
Journal:  Virology       Date:  1993-09       Impact factor: 3.616

5.  Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail.

Authors:  Stéphanie Wyss; Antony S Dimitrov; Frédéric Baribaud; Terri G Edwards; Robert Blumenthal; James A Hoxie
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

6.  Direct interaction between the envelope and matrix proteins of HIV-1.

Authors:  P Cosson
Journal:  EMBO J       Date:  1996-11-01       Impact factor: 11.598

7.  Rational site-directed mutations of the LLP-1 and LLP-2 lentivirus lytic peptide domains in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41 indicate common functions in cell-cell fusion but distinct roles in virion envelope incorporation.

Authors:  Vandana Kalia; Surojit Sarkar; Phalguni Gupta; Ronald C Montelaro
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

8.  HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes.

Authors:  Kosuke Miyauchi; Yuri Kim; Olga Latinovic; Vladimir Morozov; Gregory B Melikyan
Journal:  Cell       Date:  2009-05-01       Impact factor: 41.582

9.  Topogenic analysis of the human immunodeficiency virus type 1 envelope glycoprotein, gp160, in microsomal membranes.

Authors:  O K Haffar; D J Dowbenko; P W Berman
Journal:  J Cell Biol       Date:  1988-11       Impact factor: 10.539

10.  Important changes in biochemical properties and function of mutated LLP12 domain of HIV-1 gp41.

Authors:  Yun Zhu; Lu Lu; Lijun Chao; Ying-Hua Chen
Journal:  Chem Biol Drug Des       Date:  2007-09-10       Impact factor: 2.817

View more
  4 in total

1.  Solution Structure and Membrane Interaction of the Cytoplasmic Tail of HIV-1 gp41 Protein.

Authors:  R Elliot Murphy; Alexandra B Samal; Jiri Vlach; Jamil S Saad
Journal:  Structure       Date:  2017-10-19       Impact factor: 5.006

2.  Differentiating founder and chronic HIV envelope sequences.

Authors:  John M Murray; Stephen Maher; Talia Mota; Kazuo Suzuki; Anthony D Kelleher; Rob J Center; Damian Purcell
Journal:  PLoS One       Date:  2017-02-10       Impact factor: 3.240

Review 3.  The Interplay between HIV-1 Gag Binding to the Plasma Membrane and Env Incorporation.

Authors:  R Elliot Murphy; Jamil S Saad
Journal:  Viruses       Date:  2020-05-16       Impact factor: 5.048

Review 4.  Viral and Host Factors Regulating HIV-1 Envelope Protein Trafficking and Particle Incorporation.

Authors:  Boris Anokhin; Paul Spearman
Journal:  Viruses       Date:  2022-08-05       Impact factor: 5.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.